[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-342863-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-342863-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","novel-rei-complexes-as-potential-selective-theranostic-agents-in-cancer-cells-and-in-vivo-in-caenorhabditis-elegans-tumoral-strains","Novel Re(I) Complexes as Potential Selective Theranostic Agents in Cancer Cells and In Vivo in Caenorhabditis elegans Tumoral Strains","","A series of rhenium(I) complexes fac-[Re(CO)3(N^N)L]0/+ (Re1–Re9) was synthesized using a benzimidazole-derived bidentate ligand bearing an ester group (N^N) and either chloride or pyridine-type ligand (L). The compounds strongly inhibited ovarian A2780 cancer cells, with Re7–Re9 showing exceptional performance in 3D HeLa spheroids. The red-emitting Re9 enabled bioimaging in vitro and in vivo, including testing in C. elegans tumoral strains JK1466 and MT2124. Re9 reduced tumor growth by increasing intracellular ROS while sparing nematode development and progeny.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/novel-rei-complexes-as-potential-selective-theranostic-agents-in-cancer-cells-and-in-vivo-in-caenorhabditis-elegans-tumoral-strains/342863/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/novel-rei-complexes-as-potential-selective-theranostic-agents-in-cancer-cells-and-in-vivo-in-caenorhabditis-elegans-tumoral-strains/342863.png","ImageObject",300,407,{"name":42,"@type":43},"Ivy","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What types of rhenium(I) complexes were synthesized in this study?","Question",{"text":63,"@type":64},"Nine rhenium(I) complexes of the fac-[Re(CO)3(N^N)L]0/+ type were prepared, where N^N is a benzimidazole-derived bidentate ligand and L is chloride or a pyridine-type ligand.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which complexes showed the strongest anticancer activity?",{"text":68,"@type":64},"Re7–Re9 were the most active, with especially remarkable activity in 3D HeLa spheroids.",{"name":70,"@type":61,"acceptedAnswer":71},"How does Re9 affect tumor growth in C. elegans and what ensures selectivity?",{"text":72,"@type":64},"Re9 increased intracellular ROS levels, reducing tumor growth in JK1466 and MT2124 strains while not affecting normal nematode development and progeny.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},342863,1790754065,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":117,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":104,"preview_page_count":33,"preview_urls":144},549758252649,"https://ap-avatar.wpscdn.com/avatar/8000253669c5317157?_k=1778319167496531819","This article is licensed under CC-BY 4.0   \n[pubs.acs.org/jmc](pubs.acs.org/jmc)  Article   \nNovel Re(I) Complexes as Potential Selective Theranostic Agents in Cancer Cells and In Vivo in Caenorhabditis elegans Tumoral Strains  \nAlicia Marco,∥ Pezhman Ashoo,∥ Samanta Hernández-García, Pedro Martínez-Rodríguez, Natalia Cutillas, Annette Vollrath, Dustin Jordan, Christoph Janiak, Fernando Gandía-Herrero, * and José Ruiz*  \n Cite This: J. Med. Chem. 2024, 67, 7891−7910  \nRead Online  \n\n|  |  |  |  |  |  |\n| --- | --- | --- | --- | --- | --- |\n| ACCESS   | Metrics & More |  |  Article Recommendations |  | *sı Supporting Information |\n\nABSTRACT: A series of rhenium(I) complexes of the type fac-[Re(CO)3 (N^N)L]0/+, Re1−Re9, was synthesized, where N^N = benzimidazole-derived bidentate ligand with an ester functionality and L = chloride or pyridine-type ligand. The new compounds demonstrated potent activity toward ovarian A2780 cancer cells. The most active complexes, Re7−Re9, incorporating 4-NMe2py, exhibited remarkable activity in 3D HeLa spheroids. The emission in the red region of Re9, which contains an electron-deficient benzothiazole moiety, allowed its operability as a bioimaging tool for in vitro and in vivo visualization. Re9 effectivity was tested in two different C. elegans tumoral strains, JK1466 and MT2124, to broaden the oncogenic pathways studied. The results showed that Re9 was able to reduce the tumor growth in both strains by increasing the ROS production inside the cells. Moreover, the selectivity of the compound toward cancerous cells was remarkable as it did not affect neither the development nor the progeny of the nematodes.  \n■ INTRODUCTION  \nCancer stands as the second leading cause of death worldwide, contributing to a significant global disease burden with approximately 10 million annual deaths.1,2 Conventional cancer treatments, such as surgery, radiotherapy, and chemotherapy,3 have notable limitations, including severe side effects on healthy organs and drug resistance.4 Consequently, discovering of alternative and more selective anticancer drugs is a highly desirable goal and remains to be an active field ofresearch, where metallopharmaceuticals are playing a significant role.5−12 Smart drugs that provide a combination of diagnostics and therapy,“theranostic agents”, are of recent origin and have also received a surge of research interest.13, 14 Radioactive 186Re and 188Re have been extensively used in clinical treatment of cancer, 15, 16 and in the past decade, there has been an enormous interest in the exploitation of the rich photophysical properties of rhenium complexes for diverse imaging modalities and therapeutic biomedical applications. 17−22 In particular, rhenium carbonyl complexes have been shown to be novel anticancer agents,23,24 inhibitors of the SARS-CoV-2 main protease,25,26 and more recently therapeutic agents for schemia-reperfusion injury (IRI) .27 In general, the mechanisms of action of Re(I) anticancer complexes containing the fac-[Re(CO)3]+ core are quite distinct from that of conventional platinum agents,23,28−34 that is dependent on covalent bond formation to DNA.35 Targeting vulnerable organelles, such as the mitochondria, is one  \nstrategy that has been employed to combat resistance to chemotherapeutics,36 and that generally is the case for rhenium(I) tricarbonyl complexes.33,36−43 However, their in vivo antitumor efficacy is still little known.34,44 Our previous results on ruthenium(II) and iridium(III) organometallic complexes of the types [Ru(C^N)(N^N) 2 ] + , [Ir-(C^N)2 (N^N)]+, and [Ir(C^N)(N^N^N)]+ demonstrated that slight modifications on the benzimidazole-based ligand core rendered high anticancer activities in vitro,45−49 the Nsubstituted butyl group serving to adjust the lipophilic properties and enhance cellular uptake and targeting preferentially mitochondria,45,46 whereas the ester group attached to the benzimidazole backbone could act as a handle for further function","cbCaieiSItBuJSKc","https://ap.wps.com/l/cbCaieiSItBuJSKc","pdf",14299122,"English","# Abstract\n# Introduction\n## Background and motivation for selective anticancer agents\n## Rhenium photophysics and theranostic potential\n## Prior organometallic design insights\n# Study aims and experimental rationale","[{\"question\":\"What types of rhenium(I) complexes were synthesized in this study?\",\"answer\":\"Nine rhenium(I) complexes of the fac-[Re(CO)3(N^N)L]0/+ type were prepared, where N^N is a benzimidazole-derived bidentate ligand and L is chloride or a pyridine-type ligand.\"},{\"question\":\"Which complexes showed the strongest anticancer activity?\",\"answer\":\"Re7–Re9 were the most active, with especially remarkable activity in 3D HeLa spheroids.\"},{\"question\":\"How does Re9 affect tumor growth in C. elegans and what ensures selectivity?\",\"answer\":\"Re9 increased intracellular ROS levels, reducing tumor growth in JK1466 and MT2124 strains while not affecting normal nematode development and progeny.\"}]","Novel Re(I) Complexes as Potential Selective Theranostic Agents in Cancer Cells and In Vivo in Caenorhabditis elegans Tumoral Strains | PDF",1790048444,[145,149,153,157],{"page_no":22,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dfa9520f6da7cfa2a60a9561b3d23d31.webp",983,1296,{"page_no":26,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c2e07a50936eaac5306135e87887cf41.webp",982,1295,{"page_no":30,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5cb1b9e55f5794992f5ca31ad5b38f0e.webp",981,1293,{"page_no":33,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/64b279e0eb09f33db631943ab3440602.webp",980,1292]